US 10730835
Thalidomide analogs and methods of use
granted A61KA61K31/4035A61K31/428
Quick answer
US patent 10730835 (Thalidomide analogs and methods of use) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Health and Human Services
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4035, A61K31/428, A61K31/431, A61K31/454